# Investigating the Interactions of Peptide Nucleic Acids with Multicomponent Peptide Hydrogels for the Advancement of Healthcare Technologies

**Authors:** Sabrina Giordano, Monica Terracciano, Enrico Gallo, Carlo Diaferia, Andrea Patrizia Falanga, Antonella Accardo, Monica Franzese, Marco Salvatore, Gennaro Piccialli, Nicola Borbone, Giorgia Oliviero

PMC · DOI: 10.3390/gels11050367 · Gels · 2025-05-17

## TL;DR

This study explores how peptide hydrogels can be used to control the release of peptide nucleic acids for drug delivery in healthcare.

## Contribution

The paper introduces a tunable hydrogel system that enables controlled release of PNAs through electrostatic or covalent interactions.

## Key findings

- Hydrogels with a 1/10 ratio of modified tripeptides showed optimal structural and delivery properties.
- Electrostatic interactions enabled up to 90% PNA release, while covalent bonding provided sustained release of ~15%.
- Hydrogels exhibited high stiffness and minimal swelling under physiological conditions.

## Abstract

This study reports the development of peptide-based hydrogels for the encapsulation and controlled release of peptide nucleic acids in drug delivery applications. Ultrashort aromatic peptides, such as Fmoc-FF, self-assemble into biocompatible hydrogels with nanostructured architectures. The functionalization of tripeptides (Fmoc-FFK and Fmoc-FFC) with lysine (K) or cysteine (C) enables electrostatic or covalent interactions with model PNAs engineered with glutamic acid or cysteine residues, respectively. Hydrogels were polymerized in situ in the presence of PNAs, and component ratios were systematically varied to optimize mechanical properties, loading efficiency, and release kinetics. The formulations obtained with a 1/10 ratio of Fmoc-FF(K or C)/Fmoc-FF provided an optimal balance between structural integrity and delivery performance. All hydrogel formulations demonstrated high stiffness (G′ > 19,000 Pa), excellent water retention, and minimal swelling under physiological conditions (ΔW < 4%). The release studies over 10 days showed that electrostatic loading enabled faster and higher release (up to 90%), while covalent bonding resulted in slower, sustained delivery (~15%). These findings highlight the tunability of the hydrogel system for diverse therapeutic applications.

## Linked entities

- **Chemicals:** glutamic acid (PubChem CID 611), cysteine (PubChem CID 594)

## Full-text entities

- **Chemicals:** Fmoc-FFC (-), lysine (MESH:D008239), glutamic acid (MESH:D018698), water (MESH:D014867), Fmoc-FF (MESH:C000609769), C (MESH:D002244), PNAs (MESH:D020135), cysteine (MESH:D003545), K (MESH:D011188), peptides (MESH:D010455)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12111274/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12111274/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12111274/full.md

---
Source: https://tomesphere.com/paper/PMC12111274